Monographie - Suxamethonium chloride

Dernière mise à jour :
19/11/2024

Suxamethonium chloride

Structure chimique

Noms commerciaux

Les noms commerciaux sont donnés à titre indicatif et la composition en excipients peut être différente selon les pays et selon les laboratoires

Actirelax	Argentine
Anectine	Emirats Arabes Unis , Espagne, Etats Unis d’Amérique, Grande Bretagne, Irlande, Mexique
Celocurin	Suède
Celocurine	Belgique, France
Chlorsucillin	Pologne
Cholsuxinyl	Egypte
Cloruro de succinilcolina	Argentine
Cloruro de suxametonio	Pérou
Curacit	Norvège
Distensil	Pérou
Entubate	Inde
Ethicoline	Malaisie
Fosfitone	Argentine, Vénézuela
Lycitrope	Grèce
Lysthenon	Allemagne, Arabie Saoudite, Autriche, Emirats Arabes Unis , Roumanie, Suisse
Midarine	Arabie Saoudite, Italie, Suisse
Mioflex	Espagne, Portugal
Miokolin	Iran
Myoplegine	Belgique, Luxembourg
Myotenlis	Italie
Pantolax	Allemagne
Quelicin	Colombie
Succi	Argentine
Succinilcholina	Argentine
Succinilcholina cloruro	Pérou
Succinolin	Suisse
Succinyl	Luxembourg
Succinylcholine	Allemagne, Canada, Iran
Succyl	Iran
Sukolin	Finlande
Suxamethonium	Australie, Grande Bretagne, Iran, Irlande, Malaisie, Nouvelle Zélande
Suxametonio cloruro	Chili, Pérou
Suxim	Pérou
Uxicolin	Colombie, Mexique

Bibliographie : Suxamethonium chloride

	Type	Source
45	Revue	Schmutz CW, Mühlbach SF. Stability of succinylcholine chloride injection. Am J Hosp Pharm 1991 ; 48: 501-506.
300	Revue	Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319	Revue	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
667	Revue	Pramar YV, Moniz D, Hobbs D. Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes. J Clin Pharm Ther 1994 ; 19: 195-198.
1050	Revue	Boehm JJ, Dutton DM, Poust RI. Shelf life of unrefrigerated succinylcholine chloride injection. Am J Hosp Pharm 1984 ; 41: 300-302.
1721	Revue	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1755	Revue	Storms ML, Stewart JT, Warren FW. Stability of succinylcholine chloride injection at ambient temperature and 4°C in polypropylene syringes. Int J Pharm Compound 2003 ; 7: 68-70.
2215	Revue	Boehm J.J, Poust R.I. Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5. Chem Pharm Bull 1984 ; 32, 3: 1113-1119.
2227	Revue	Trusley C, Ben M, Kupiec TC, Trissel LA. Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration. Int J Pharm Compound 2008 ; 12, 2: 156-160.
2360	Revue	Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P. Room temperature stability of injectable succinylcholine dichloride. Int J Pharm Compound 2008 ; 12, 1: 83-85.
3373	Revue	Khan S, Stannard N, Greijn J. Precipitation of thiopental with muscle relaxants: a potential hazard. J R Soc Med Sh Rep 2011 ; 2: 58.
3631	Laboratoire	Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit Aguettant 2016
3932	Laboratoire	Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit Serb Laboratoire 2015
4274	Revue	Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J. Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method. J Clin Anesth 2016 ; 35: 551-559.
4528	Revue	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61

Mentions Légales